Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Explora BioLabs, a national provider of preclinical vivarium space, vivarium management services, and contract research services, announced it has completed its acquisition of Novalex Biotech Resources, LLC, a vivarium service provider based here.
read more
Friday, November 14, 2014
The Lubrizol Corporation announces an alliance between Lubrizol LifeSciences, a leading supplier of advanced materials for the healthcare industry, and
Particle Sciences, an integrated provider of drug development services.
read more
Wednesday, September 19, 2018
Emmaus Life Sciences has entered into a distribution agreement with Cardinal Health.
read more
Thursday, October 04, 2018
Catalent Pharma Solutions announced it completed the first phase of a $7.3 million investment to upgrade and expand its packaging and softgel encapsulation capabilities at its facility in Aprilia, Italy.
read more
WuXi Biologics announced the launch of WuXiHigh™2.0, a high-throughput formulation development platform designed for high concentration biologics. The platform enables protein concentrations of up to 230 mg/mL and achieves viscosity reduction by up ...
read more
WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading pharmaceutical, biotechnology and medical device R&D services company with operations in China and the United States, and Pacific Biomarkers (PBI), a premier biomarker laboratory services provider ...
read more
Tuesday, November 29, 2016
Patheon has signed a definitive agreement to acquire a state-of-the-art active pharmaceutical ingredients (API) manufacturing facility in Florence, South Carolina, from Roche Holdings, Inc., an indirect, wholly owned subsidiary of Roche Holding Ltd.,...
read more
Sosei will apply its structure-based drug design platform and capabilities to the global research efforts to discover drugs targeting the SARS-CoV-2 coronavirus and to treat COVID-19.
read more
Partners Group, a global private markets investment manager, acting on behalf of its clients, and the Public Sector Pension Investment Board, one of Canada's largest pension investment managers, have agreed to acquire European medical laboratory ...
read more
Tuesday, September 26, 2017
Selexis and OSE announced the signing of two CLAs that provide OSE with access to high-performance RCBs developed using the Selexis SUREtechnology Platform.
read more
Wednesday, October 11, 2017
Envigo announced the appointment of Dr. Naheed Rehman as new business lead consultant, chemicals.
read more
Wednesday, February 17, 2021
Recipharm, has extended its manufacturing license to include immunology products.
read more
Monday, November 06, 2017
Gattefossé USA and Gattefossé Canada announce their partnership with SIO to bring highly refined USP/NF grade injectable oils to the North American pharmaceutical product development market.
read more
Monday, November 19, 2018
Alvotech and Fuji Pharma announce that the two companies are entering into an exclusive partnership for the commercialization by Fuji Pharma of Alvotech’s biosimilar portfolio in Japan.
read more
Crescita has received the second installment of the up-front payment related to the out-licensing of Pliaglis in Italy, France, Spain and Portugal, from its partner, Cantabria Labs.
read more